Ian A Smith

Title: Ian A. Smith: Innovator in Neuroactive Peptides

Introduction

Ian A. Smith is a distinguished inventor based in Hampton, Australia. He has made significant contributions to the field of neuroactive peptides, particularly through his innovative patent. His work focuses on the modulation of neuronal activity, which has important implications for pharmaceutical applications.

Latest Patents

Ian A. Smith holds a patent for the invention titled "LV V-Haemorphin-7 neuroactive peptide and methods of use." This invention relates to neuroactive peptides or analogues that possess at least one of the biological activities of angiotensin IV. The peptide sequence involved is Leu-Val-Val-Tyr-Pro-Trp-Thr-Gln-Arg-Phe. This patent outlines methods for modulating neuronal activity and includes pharmaceutical compositions that utilize these peptides.

Career Highlights

Ian A. Smith is affiliated with the Howard Florey Institute of Experimental Physiology, where he conducts research and development in neurobiology. His work has contributed to a deeper understanding of neuroactive compounds and their potential therapeutic uses.

Collaborations

Ian has collaborated with notable colleagues in his field, including Frederick A. O. Mendelsohn and Siew Yeen Chai. These collaborations have furthered research efforts and enhanced the impact of their collective work in neuroactive peptides.

Conclusion

Ian A. Smith is a prominent figure in the field of neuroactive peptides, with a patent that showcases his innovative approach to modulating neuronal activity. His contributions to the Howard Florey Institute and collaborations with esteemed colleagues highlight his commitment to advancing scientific knowledge in this important area.